Supplements

Baseline insomnia severity modifies the association between sleep efficiency and next-day daytime HRV (RMSSD) in a predominantly healthy cohort

In a wearable-based dataset of 49 participants over 4 weeks, the interaction between CSD-style sleep efficiency and baseline Insomnia Severity Index (ISI) was positively associated with next-day daytime RMSSD (β=0.0060; 95% CI, 0.0023 to 0.0097; P=0.002). This suggests that individuals with higher baseline insomnia symptoms show a stronger positive coupling between sleep efficiency and next-day heart rate variability.

Last updated: Jul 27, 20260 RCTs📖 Read as article →

Evidence Score

Evidence Score34/100
Human RCT☆☆☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★
Confidencelow

Study Evidence

Study 1. Insomnia severity modifies diary-based sleep-continuity and sleep-initiation associations with next-day daytime HRV in a real-world wearable dataset.

observational

Meng X, Cai M · Digital health (2026)

Participants: N/A
Duration: 4 weeks
Intervention: Baseline insomnia severity (measured by Insomnia Severity Index) as a modifier of sleep-diary metrics (sleep efficiency, sleep latency, WASO, sleep duration)
Outcome: Next-day daytime heart rate variability (RMSSD, natural log transformed)
Effect Size: β=0.0060 (95% CI, 0.0023 to 0.0097) for sleep efficiency × ISI interaction
Population: 49 participants from a publicly available wearable dataset, predominantly healthy with non-severe baseline insomnia symptoms (no participant met criteria for severe baseline insomnia)

Result:

Mechanism Graph

Baseline insomnia severity is measured using the Insomnia Severity Index
Daily sleep efficiency is derived from Consensus Sleep Diary-style definitions
Daytime HRV (RMSSD) is aggregated from 5-minute windows between 09:00 and 23:00
Higher baseline ISI modifies the positive association between sleep efficiency and next-day RMSSD

Limitations

  • Higher-ISI estimates were based on few participants in the moderate-ISI range and on person-days meeting daytime HRV coverage criteria
  • Findings should not be extrapolated to populations with severe or clinically diagnosed insomnia
  • Secondary analysis of a publicly available dataset with potential selection bias

Frequently Asked Questions

What is the primary finding of this study?

The study found that baseline insomnia severity modifies the association between sleep efficiency and next-day daytime heart rate variability (RMSSD), with a positive interaction (β=0.0060).

How was sleep efficiency measured?

Sleep efficiency was operationalized using a Consensus Sleep Diary (CSD)-style definition that explicitly incorporated wake after sleep onset (WASO).

What population was studied?

The study included 49 participants from a publicly available wearable dataset, with predominantly non-severe baseline insomnia symptoms; no participant had severe baseline insomnia.

What were the key limitations of the study?

Key limitations include small sample size for higher-ISI estimates, reliance on person-days meeting HRV coverage criteria, and inability to generalize to severe or clinically diagnosed insomnia populations.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Meng X, Cai M. "Insomnia severity modifies diary-based sleep-continuity and sleep-initiation associations with next-day daytime HRV in a real-world wearable dataset.." Digital health, 2026. PMID: 42460158 DOI: 10.1177/20552076261469378
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.